Literature DB >> 29264431

Gastrointestinal stromal tumors-are we stuck and the way forward.

Umang Swami1, Varun Monga1, Mohammed Milhem1.   

Abstract

Entities:  

Year:  2017        PMID： 29264431      PMCID： PMC5723736          DOI： 10.21037/tgh.2017.11.07

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  17 in total

1.  Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.

Authors:  Daniela Gasparotto; Sabrina Rossi; Maurizio Polano; Elena Tamborini; Erica Lorenzetto; Marta Sbaraglia; Alessia Mondello; Marco Massani; Stefano Lamon; Raffaella Bracci; Alessandra Mandolesi; Elisabetta Frate; Franco Stanzial; Jerin Agaj; Guido Mazzoleni; Silvana Pilotti; Alessandro Gronchi; Angelo Paolo Dei Tos; Roberta Maestro
Journal:  Clin Cancer Res       Date:  2016-07-07       Impact factor: 12.531

Review 2.  Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review.

Authors:  Peter J Oppelt; Angela C Hirbe; Brian A Van Tine
Journal:  J Gastrointest Oncol       Date:  2017-06

Review 3.  Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors.

Authors:  Amber E Bannon; Lillian R Klug; Christopher L Corless; Michael C Heinrich
Journal:  Expert Rev Mol Diagn       Date:  2017-03-27       Impact factor: 5.225

Review 4.  Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future Directions.

Authors:  Sheena Bhalla; Douglas Tremblay; John Mascarenhas
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-06-16

Review 5.  Promising novel therapeutic approaches in the management of gastrointestinal stromal tumors.

Authors:  Zoltan Szucs; Khin Thway; Cyril Fisher; Ramesh Bulusu; Anastasia Constantinidou; Charlotte Benson; Winette Ta van der Graaf; Robin L Jones
Journal:  Future Oncol       Date:  2016-09-07       Impact factor: 3.404

Review 6.  Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors.

Authors:  César Serrano; Suzanne George; Claudia Valverde; David Olivares; Alfonso García-Valverde; Cristina Suárez; Rafael Morales-Barrera; Joan Carles
Journal:  Target Oncol       Date:  2017-06       Impact factor: 4.493

7.  Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study.

Authors:  Grace L Ma; James D Murphy; Maria E Martinez; Jason K Sicklick
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-02       Impact factor: 4.254

8.  Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors.

Authors:  Ann W Gramza; Christopher L Corless; Michael C Heinrich
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

Review 9.  Can Imatinib Be Safely Withdrawn in Patients with Surgically Resected Metastatic GIST?

Authors:  Ivar Hompland; Øyvind S Bruland
Journal:  Anticancer Res       Date:  2015-11       Impact factor: 2.480

10.  Gastrointestinal stromal tumor.

Authors:  Xiaohui Zhao; Changjun Yue
Journal:  J Gastrointest Oncol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.